CALT - Cup and HandleAn idea showing a clear Cup or rounded formation on CALT.
Im just forecasting a handle situation due to the fact of the presence of this cup.
Price is above a down channel which is good for this scenario.
−8.7SEK
−466.19 MSEK
1.21 BSEK
38.11 M
About CALLIDITAS THERAPEUTICS AB
Sector
CEO
Renée Julie Elisabet Aguiar-Lucander
Headquarters
Stockholm
Website
Founded
2004
ISIN
SE0010441584
FIGI
BBG00B4MYMF0
Calliditas Therapeutics AB clinical-stage biopharmaceutical company. It engages in the identification, development, and commercialization of novel treatments in orphan indications. The firm focuses on renal and hepatic diseases with significant unmet medical needs. It offers Nefecon, a proprietary, novel oral formulation of budesonide for the treatment of the autoimmune renal disease IgA nephropathy, or IgAN. The firm product TARPEYO is used to reduce proteinuria in adults with primary immunoglobulin. The company was founded by Mikael Bender and Bengt Åke Julander on February 20, 2004 and is headquartered in Stockholm, Sweden.
CALT BUY/LONG NOW READY! 31.00 to 39.45 by Aug 2021TICKER CODE: CALT
Company Name: CALLIDITAS THERAPEUTICS AB
US Stocks Health Technology Pharmaceuticals: Major
Position Proposed: BUY
BUY ENTRY: NOW READY (31.00)
1st Partial Take Profit: 39.45 (July - August 2021)
2nd Partial Take Profit: 47.80 (End 2021)
NOTE THAT THE TIMELINE IS ONLY AN ESTIMA
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CALTX is 99.5 SEK — it has decreased by 1.44% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange CALLIDITAS THERAPEUTICS AB stocks are traded under the ticker CALTX.
CALLIDITAS THERAPEUTICS AB is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
CALTX stock is 6.01% volatile and has beta coefficient of 0.16. Check out the list of the most volatile stocks — is CALLIDITAS THERAPEUTICS AB there?
One year price forecast for CALLIDITAS THERAPEUTICS AB has a max estimate of 300.0 SEK and a min estimate of 89.9 SEK.
CALTX earnings for the last quarter are −0.17 SEK whereas the estimation was −0.71 SEK which accounts for 76.18% surprise. Estimated earnings for the next quarter are −0.94 SEK. See more details about CALLIDITAS THERAPEUTICS AB earnings.
CALLIDITAS THERAPEUTICS AB revenue for the last quarter amounts to 294.60 M SEK despite the estimated figure of 325.23 M SEK. In the next quarter revenue is expected to reach 360.45 M SEK.
Yes, you can track CALLIDITAS THERAPEUTICS AB financials in yearly and quarterly reports right on TradingView.
CALTX stock has fallen by 11.21% compared to the previous week, the month change is a 9.26% fall, over the last year CALLIDITAS THERAPEUTICS AB has showed a 20.95% decrease.
CALTX net income for the last quarter is −18.37 M SEK, while the quarter before that showed −168.36 M SEK of net income which accounts for 89.09% change. Track more CALLIDITAS THERAPEUTICS AB financial stats to get the full picture.
Today CALLIDITAS THERAPEUTICS AB has the market capitalization of 5.42 B, it has increased by 1.87% over the last week.
No, CALTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CALTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CALLIDITAS THERAPEUTICS AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CALLIDITAS THERAPEUTICS AB technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CALLIDITAS THERAPEUTICS AB stock shows the sell signal. See more of CALLIDITAS THERAPEUTICS AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on CALLIDITAS THERAPEUTICS AB future price: according to them, CALTX price has a max estimate of 300.00 SEK and a min estimate of 89.91 SEK. Read a more detailed CALLIDITAS THERAPEUTICS AB forecast: see what analysts think of CALLIDITAS THERAPEUTICS AB and suggest that you do with its stocks.